类风湿关节炎患者起始甲氨蝶呤治疗不依从的预测因素与原因
RAMS前瞻性多中心队列纳入606例起始MTX的RA患者,26周日记法评估发现26%曾不依从(71%有意)。DAS28、疲劳、≥2种合并症及药物顾虑-需求差值为不依从的独立预测因素。
要点
- 26%的RA患者在起始MTX后6个月内曾出现不依从,其中71%为有意不依从。
- DAS28、疲劳、≥2种合并症及高药物顾虑是早期不依从的独立预测因素。
- 患者信念与多病共存是改善MTX依从性的潜在干预靶点。
核心结论
- RA患者起始MTX后6个月内26%曾不依从,以有意不依从为主,患者信念与多病共存与不依从强烈相关。
研究设计与样本
- RAMS为英国前瞻性多中心队列研究,纳入606例起始MTX的RA患者,基线收集人口学、临床及心理数据,每周日记记录26周MTX剂量、副作用与依从性。
- 采用logistic回归分析识别6个月内曾不依从(≥1周不依从)的基线预测因素。
主要发现
- 606例RA患者中69%为女性,平均(标准差)年龄60(13)岁,DAS28评分4.2(1.2)。
- 6个月内158例(26%)曾不依从,其中71%为有意、19%为无意、10%原因不明;平均(标准差)不依从周数为2.5(2.1)。
- 多变量预测因素包括DAS28(OR 1.1,95%CI 1.0,1.4)、疲劳(每cm OR 1.1,95%CI 1.0,1.2)、≥2种合并症 vs 无合并症(OR 1.9,95%CI 1.1,3.5)及高药物顾虑-需求差值(每单位下降 OR 1.1,95%CI 1.0,1.1)。
临床怎么用
- 对起始MTX的RA患者应评估DAS28、疲劳、合并症负担及药物信念,识别不依从高风险者。
- 针对患者药物顾虑与多病共存设计干预,可能改善早期MTX依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In order to develop interventions to optimize MTX use for the treatment of RA we evaluated the rate of, reasons for and predictors of MTX non-adherence during the first 6 months of therapy. METHODS: The Rheumatoid Arthritis Medication Study (RAMS) is a prospective multicentre cohort study of incident MTX users in the UK. Prior to MTX commencement demographic, clinical and psychological data were collected. A weekly patient-completed diary recorded MTX dose, possible side effects and adherence over 26 weeks. The number of non-adherent weeks was calculated. Potential baseline predictors of ever non-adherence (⩾1 week non-adherent) during the first 6 months of MTX therapy were identified using logistic regression analyses. RESULTS: 606 patients with RA were included; 69% female, mean (s.d.) age 60 (13) years and DAS28 score 4.2 (1.2). Over the first 6 months following MTX initiation, 158 (26%) patients were ever non-adherent (71% intentional, 19% non-intentional, 10% unexplained) and mean (s.d.) number of non-adherent weeks was 2.5 (2.1). Multivariable predictors of ever non-adherence included DAS28 [odds ratios (OR) 1.1, 95% CI 1.0, 1.4], fatigue (OR 1.1, 95% CI 1.0, 1.2 per cm), ⩾2 comorbidities vs no comorbidities (OR 1.9, 95% CI 1.1, 3.5) and high medication concerns despite perceived need (OR 1.1, 95% CI 1.0, 1.1 per unit decrease in need/concern differential). CONCLUSION: This is the largest study evaluating early intentional and non-intentional non-adherence to MTX, which has identified that patient beliefs and multi-morbidity strongly link with non-adherence. These findings can direct the design of and provide potential targets for interventions to improve patient adherence.
引用
- Hope HF, Hyrich KL, Anderson J, et al. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford). 2020. PMID: 31302692. doi:10.1093/rheumatology/kez274
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。